These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 12224679)

  • 21. Electronic health record phenotyping improves detection and screening of type 2 diabetes in the general United States population: A cross-sectional, unselected, retrospective study.
    Anderson AE; Kerr WT; Thames A; Li T; Xiao J; Cohen MS
    J Biomed Inform; 2016 Apr; 60():162-8. PubMed ID: 26707455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of undiagnosed Type-2-diabetes mellitus and impaired fasting glucose in German primary care: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS).
    Hauner H; Hanisch J; Bramlage P; Steinhagen-Thiessen E; Schunkert H; Jöckel KH; Wasem J; Moebus S
    Exp Clin Endocrinol Diabetes; 2008 Jan; 116(1):18-25. PubMed ID: 17926235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How diabetes risk assessment tools are implemented in practice: a systematic review.
    Dhippayom T; Chaiyakunapruk N; Krass I
    Diabetes Res Clin Pract; 2014 Jun; 104(3):329-42. PubMed ID: 24485859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Validation of an instrument for screening cases of type 2 diabetes and monitoring at-risk individuals in Mexico].
    Guerrero-Romero F; Rodríguez-Morán M
    Rev Panam Salud Publica; 2010 Mar; 27(3):181-6. PubMed ID: 20414507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The need for frank discussions about weight.
    Williams AN
    BMJ; 2015 Sep; 351():h5003. PubMed ID: 26405043
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening: A risk-based framework to decide who benefits from screening.
    Castle PE; Katki HA
    Nat Rev Clin Oncol; 2016 Sep; 13(9):531-2. PubMed ID: 27323876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Results Are Not a Basis for Screening.
    Abholz HH
    Dtsch Arztebl Int; 2023 Jul; 120(29-30):507. PubMed ID: 37981821
    [No Abstract]   [Full Text] [Related]  

  • 29. [Colorectal carcinoma screening in patients with type 2 diabetes mellitus].
    Nagel JM; Göke B
    Z Gastroenterol; 2006 Nov; 44(11):1153-65. PubMed ID: 17115358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic yield of screening for type 2 diabetes in high-risk patients: a systematic review.
    Rao G
    J Fam Pract; 1999 Oct; 48(10):805-10. PubMed ID: 12224679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes.
    Khunti K; Mani H; Achana F; Cooper N; Gray LJ; Davies MJ
    PLoS One; 2015; 10(9):e0135702. PubMed ID: 26325182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation.
    Barengo NC; Tamayo DC; Tono T; Tuomilehto J
    Prim Care Diabetes; 2017 Feb; 11(1):86-93. PubMed ID: 27727004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000.
    Rathmann W; Martin S; Haastert B; Icks A; Holle R; Löwel H; Giani G;
    Arch Intern Med; 2005 Feb; 165(4):436-41. PubMed ID: 15738374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.